Upcoming WRIB Meeting:
Past WRIB Meetings in the Last 10 Years:
19th WRIB (Workshop on Recent Issues in Bioanalysis)
April 7-11, 2025, New Orleans, LA, USA
Hilton New Orleans Riverside (2 Poydras St, New Orleans, LA, USA 70130)
18th WRIB (Workshop on Recent Issues in Bioanalysis)
May 6-10, 2024, San Antonio, TX, USA
Marriott Rivercenter on the River Walk (101 Bowie St, San Antonio, TX, USA 78205)
17th WRIB (Workshop on Recent Issues in Bioanalysis)
June 19-23, 2023, Orlando Disney Springs, FL, USA
Hilton Orlando Lake Buena Vista (1751 Hotel Plaza Blvd, Lake Buena Vista, FL, USA 32830)
16th WRIB (Workshop on Recent Issues in Bioanalysis)
September 26-30, 2022, Atlanta, GA, USA
Hilton Atlanta (255 Courtland St NE, Atlanta, GA, USA 30303)
15th WRIB (Workshop on Recent Issues in Bioanalysis)
September 27-October 1, 2021
Virtual
14th WRIB (Workshop on Recent Issues in Bioanalysis)
June 15-29, 2020
Virtual
13th WRIB (Workshop on Recent Issues in Bioanalysis)
April 1-5, 2019, New Orleans, LA, USA
Hyatt Regency New Orleans (601 Loyola Ave, New Orleans, LA 70113, USA)
12th WRIB (Workshop on Recent Issues in Bioanalysis)
April 9-13, 2018, Philadelphia, PA, USA
Sheraton Philadelphia Downtown (201 N 17th St, Philadelphia, PA 19103, USA)
11th Workshop on Recent Issues in Bioanalysis (11th WRIB)
April 3 - 7, 2017, Los Angeles, CA, USA
Hilton Los Angeles/Universal City (555 Universal Hollywood Dr, Los Angeles, CA 91608)
10th Workshop on Recent Issues in Bioanalysis (10th WRIB)
April 18 - 22, 2016, Downtown Disney® Orlando, FL, USA
Hilton Orlando Lake Buena Vista (1751 Hotel Plaza Blvd, Lake Buena Vista, FL, USA 32830)
9th Workshop on Recent Issues in Bioanalysis (9th WRIB)
April 13–17, 2015, Miami, FL, USA
Hilton Miami Downtown (1601 Biscayne Bouleverd, Miami, FL 33132)
Published White Papers from WRIB Meetings in the Last 10 Years
2024 White Paper in Bioanalysis
This 2024 White Paper encompasses recommendations emerging from the extensive discussions held during the 18th WRIB in San Antonio, TX, USA on May 6-10, 2024 and is aimed to provide the bioanalytical community with key information and practical solutions on topics and issues addressed, in an effort to enable advances in scientific excellence, improved quality and better regulatory compliance. Due to its length, the 2024 edition of this comprehensive White Paper has been divided into three parts for editorial reasons and published on the Bioanalysis Journal (Taylor & Francis Group, UK).
WRIB Special Focus White Paper on Vaccine Ligand Binding Assays Validation
The urgency and importance of organizing a global effort to harmonize clinical assay validation specific to the vaccine industry was identified during the drafting of the 2020 White Paper in Bioanalysis due to the lack of clarity and regulatory guidance/guidelines in vaccine immunoassay validation. In early 2021, Vaccine manufacturers approached WRIB for sponsoring/supporting the authorship and publication of an overarching vaccine assay validation document based on the 2017–2020 discussions and consensus. This White Paper is the first global effort to guide vaccine clinical assay validation work. For too long, vaccine scientists have not had a clear validation guidance for clinical vaccine immunogenicity assays. We hope that this common effort will help close this regulatory gap
2023 White Paper in Bioanalysis
This 2023 White Paper encompasses recommendations emerging from the extensive discussions held during the 17th WRIB in Orlando, FL, USA on June 19-23, 2023 and is aimed to provide the bioanalytical community with key information and practical solutions on topics and issues addressed, in an effort to enable advances in scientific excellence, improved quality and better regulatory compliance. Due to its length, the 2023 edition of this comprehensive White Paper has been divided into three parts for editorial reasons and published on the Bioanalysis Journal (Taylor & Francis Group, UK).
2022 White Paper in Bioanalysis
was based on the conclusions and consensus points from the 16th WRIB in September 2022 in Atlanta. It was divided into 3 parts due to length, and was published on the Bioanalysis Journal (Future Science, UK).
2021 White Paper in Bioanalysis
was based on the conclusions and consensus points from the 15th WRIB in September 2021. It was divided into 3 parts due to length, and was just published on the Bioanalysis Journal (Future Science, UK).
2020 White Paper in Bioanalysis
was based on the conclusions and consensus points from the 14th WRIB in June 2020. It was divided into 3 parts due to length, and was just published on the Bioanalysis Journal (Future Science, UK).
2019 White Paper in Bioanalysis, Biomarkers, Immunogenicity and Gene Therapy
was based on the conclusions and consensus points from the 13th WRIB in April 2019 in New Orleans. It was divided into 3 parts due to length, and was just published on Journal Bioanalysis.
2018 White Paper in Bioanalysis, Biomarkers and Immunogenicity
was based on the conclusions and consensus points from the 12th WRIB in April 2018 in Philadelphia. It was divided into 3 parts due to length, and was published on Journal Bioanalysis.
2017 White Paper in Bioanalysis, Biomarkers and Immunogenicity
was based on the conclusions and consensus points from the 11th WRIB in April 2017 in Los Angeles. It was divided into 3 parts due to length, and was published on Journal Bioanalysis.
Decennial Index of all the recommendations from the last 10 years' WRIB White Papers to help you search easily by topics and see the evolution of the recommendations on the same topic over the years.
2016 White Paper in Bioanalysis: Focus on Biomarker Assay Validation (BAV) from the 10th WRIB in April 2016 in Orlando. It was divided into 3 parts due to length.
2015 White Paper on Recent Issues in Bioanalysis: Focus on New Technologies & Biomarkers
was based on the conclusions and consensus points from the 9th WRIB in April 2015 in Miami. It was divided into 3 parts due to length to be published on Journal Bioanalysis.
2014 White Paper on Recent Issues in Bioanalysis: A Full Immersion in Bioanalysis
was based on the conclusions and consensus points from the 8th WRIB in March 2014 in Los Angeles. It was divided into 3 parts due to length, and was published on the Bioanalysis Journal (Future Science, UK).